UBS Analysts Say Synergies May Justify Improved Challenger Offer
UBS analysts say capital and cost synergies Daiichi Life could extract from Australian annuity provider Challenger may justify an improved offer.
UBS analysts say capital and cost synergies Daiichi Life could extract from Australian annuity provider Challenger may justify an improved offer.